LIVE MARKET TRACKER :   BSE SENSEX   31599.76      |    NSE NIFTY 9871.50    
GLOBAL MARKETS :  NASDAQ 6370.5898   -0.8765%    |    FSI London 7304.95   +0.05%    |    NIKKEI Japan 20330.19   -0.33%
  USD GBP EUR CAD AUD INR
USD - 0.7452 0.8486 1.2384 1.2678 65.6200
GBP 1.3419 - 1.1387 1.6614 1.7011 88.1017
EUR 1.1787 0.8784 - 1.4594 1.4942 77.3449
CAD 0.8078 0.6024 0.6854 - 1.0244 53.0200
AUD 0.7889 0.5880 0.6695 0.9768 - 51.7650
INR 0.0153 0.0114 0.0129 0.0189 0.0194 -
Indian-Commodity  :  Corporate  :  Bank of India plans to divest stake in some other non-core subsidiaries

Bank of India plans to divest stake in some other non-core subsidiaries (05-Jun-2017)

Bank of India is exploring opportunities to divest stake in some other non-core subsidiaries depending on right valuation. This step is taken in order to unlock capital and turn the corner as it has been saddled with bad loans.

The bank's gross non-performing assets (NPAs) or bad loans were restricted to 13.22% of the gross advances at the end of March 2017, marginally higher than 13.07% a year ago. Net NPAs however declined to 6.90% of the net advances at the end of last fiscal, as against 7.79% a year earlier.

The Bank has reported a net loss of Rs 1045.54 crore for the quarter ended March 31, 2017 as compared to a net loss of Rs 3587.11 crore for the same quarter in the previous year. However, total income of the Bank increased by 8.35% at Rs 12335.71 crore for quarter under review as compared to Rs 11384.91 crore for the quarter ended March 31, 2016.




Top News Today
Jaiprakash Associates gets nod to raise up to Rs 2,000 crore
(26-Sep-2017)

Jaiprakash Associates gets nod to raise up to Rs 2,000 croreJaiprakash Associates has received its shareholders' approval to raise up to Rs 2,000 crore through sale of securities. The special resolution was approved by the shareholders at the company's annual general......click on news to read complete article.

Panacea Biotec planning to raise Rs 250 crore
(26-Sep-2017)

Panacea Biotec planning to raise Rs 250 crorePanacea Biotec is planning to raise Rs 250 crore by way of issue of equity shares and/or other securities. In this regards, the company is conducting Postal Ballot for obtaining approval of members for......click on news to read complete article.

Novartis India gets nod for Rs 231.15 crore buyback plan
(26-Sep-2017)

Novartis India gets nod for Rs 231.15 crore buyback planNovartis India has received an approval for buyback of up to 34.5 lakh shares, accounting for about 12.26% of the existing paid up capital of the company, for up to Rs 231.15 crore. The company's board......click on news to read complete article.

International Stock News
Asian markets trade mostly lower in early deals on Tuesday
(26-Sep-2017)

Asian markets trade mostly lower in early deals on TuesdayMost of the Asian equity benchmarks are trading down in the early deals on Tuesday, following declines on Wall Street overnight, as the war of words between North Korea and the US escalated. Meanwhile,......click on news to read complete article.

US markets closed lower on North Korea's threat
(26-Sep-2017)

US markets closed lower on North KoreaThe US markets closed lower on Monday, on the back of a fresh flare up in tensions between the US and North Korea and a sharp decline in technology shares. North Korean foreign minister Ri Yong Ho, speaking......click on news to read complete article.

Asian markets trade mostly lower in early deals on Monday
(25-Sep-2017)

Asian markets trade mostly lower in early deals on MondayMost of the Asian equity benchmarks are trading down in the early deals on Monday, following the lackluster cues from Wall Street and concerns about China's economy. Investors digested election results......click on news to read complete article.

 

     
  
Recent Corporate News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.